319 related articles for article (PubMed ID: 30322153)
21. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
Drews CM; Case S; Vande Pol SB
PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
[TBL] [Abstract][Full Text] [Related]
22. Wnt-11 overexpression promoting the invasion of cervical cancer cells.
Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang S
Tumour Biol; 2016 Sep; 37(9):11789-11798. PubMed ID: 27034261
[TBL] [Abstract][Full Text] [Related]
23. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.
Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J
Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046
[TBL] [Abstract][Full Text] [Related]
24. Genetic variations in human papillomavirus and cervical cancer outcomes.
Rader JS; Tsaih SW; Fullin D; Murray MW; Iden M; Zimmermann MT; Flister MJ
Int J Cancer; 2019 May; 144(9):2206-2214. PubMed ID: 30515767
[TBL] [Abstract][Full Text] [Related]
25. HPV16 E6 and E6AP differentially cooperate to stimulate or augment Wnt signaling.
Sominsky S; Kuslansky Y; Shapiro B; Jackman A; Haupt Y; Rosin-Arbesfeld R; Sherman L
Virology; 2014 Nov; 468-470():510-523. PubMed ID: 25262469
[TBL] [Abstract][Full Text] [Related]
26. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
27. E6 proteins of α and β cutaneous HPV types differ in their ability to potentiate Wnt signaling.
Sominsky S; Shterzer N; Jackman A; Shapiro B; Yaniv A; Sherman L
Virology; 2017 Sep; 509():11-22. PubMed ID: 28586650
[TBL] [Abstract][Full Text] [Related]
28. Reduced MAGI3 level by HPV18E6 contributes to Wnt/β-catenin signaling activation and cervical cancer progression.
Yang Z; Liu H; Song R; Lu W; Wang H; Gu S; Cao X; Chen Y; Liang J; Qin Q; Yang X; Feng D; He J
FEBS Open Bio; 2021 Nov; 11(11):3051-3062. PubMed ID: 34510826
[TBL] [Abstract][Full Text] [Related]
29. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
30. The Deubiquitinase USP46 Is Essential for Proliferation and Tumor Growth of HPV-Transformed Cancers.
Kiran S; Dar A; Singh SK; Lee KY; Dutta A
Mol Cell; 2018 Dec; 72(5):823-835.e5. PubMed ID: 30415951
[TBL] [Abstract][Full Text] [Related]
31. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
32. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus (HPV) oncoprotein E6 facilitates Calcineurin-Nuclear factor for activated T cells 2 (NFAT2) signaling to promote cellular proliferation in cervical cell carcinoma.
Ram BM; Dolpady J; Kulkarni R; Usha R; Bhoria U; Poli UR; Islam M; Trehanpati N; Ramakrishna G
Exp Cell Res; 2018 Jan; 362(1):132-141. PubMed ID: 29129565
[TBL] [Abstract][Full Text] [Related]
34. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus E6 interaction with cellular PDZ domain proteins modulates YAP nuclear localization.
Webb Strickland S; Brimer N; Lyons C; Vande Pol SB
Virology; 2018 Mar; 516():127-138. PubMed ID: 29346075
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
[TBL] [Abstract][Full Text] [Related]
37. NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.
Vliet-Gregg PA; Robinson KL; Levan J; Matsumoto LR; Katzenellenbogen RA
Cancer Lett; 2019 May; 449():106-113. PubMed ID: 30776478
[TBL] [Abstract][Full Text] [Related]
38. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
[TBL] [Abstract][Full Text] [Related]
39. Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines.
Deshpande R; Mansara P; Kaul-Ghanekar R
Tumour Biol; 2016 Mar; 37(3):3295-305. PubMed ID: 26440049
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
